Amylyx Pharmaceuticals Inc [NASDAQ: AMLX] traded at a low on Thursday, posting a -5.32 loss after which it closed the day’ session at $1.78. The results of the trading session contributed to over 2476759 shares changing hands. Over the past one week, the price volatility
Amylyx Pharmaceuticals Inc [NASDAQ: AMLX] traded at a low on Thursday, posting a -6.91 loss after which it closed the day’ session at $2.29. The company report on April 10, 2024 at 9:00 AM that Amylyx Pharmaceuticals Announces Interim Data From Ongoing Phase 2 HELIOS
Amylyx Pharmaceuticals Inc [NASDAQ: AMLX] loss -0.76% on the last trading session, reaching $2.61 price per share at the time. The company report on April 4, 2024 at 7:00 AM that Amylyx Pharmaceuticals Announces Formal Intention to Remove RELYVRIO®/ALBRIOZA™ from the Market; Provides Updates on
Amylyx Pharmaceuticals Inc [NASDAQ: AMLX] plunged by -$15.61 during the normal trading session on while it closed the day at $3.36. The company report on March 8, 2024 at 7:00 AM that Amylyx Pharmaceuticals Announces Topline Results From Global Phase 3 PHOENIX Trial of AMX0035
Amylyx Pharmaceuticals Inc [NASDAQ: AMLX] gained 21.10% on the last trading session, reaching $18.54 price per share at the time. The company report on February 22, 2024 at 7:00 AM that Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results. Reported $380.8 million
© 2024, Powered by Smart TechOne
